Power Law company profile

Amicus Therapeutics

Biotech & Life Sciences · Philadelphia, United States · Founded 2002 · IPO 2007 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$4.70B

Market cap · Apr/2026

Revenue

$634M

Latest reported FY

Investors

9 investors on Amicus Therapeutics's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 1 investor entered at this stage

CHL Medical Partners

Series B+ 8 investors entered at this stage

Palo Alto Investors

Frazier Healthcare Partners

NEA

Prospect Venture Partners

Radius Ventures

Canaan

Quaker Bio Ventures

Global footprint

Where Amicus Therapeutics has talent and traffic

AI talent share

0.2% of workforce is AI talent
(1 of 629 staff)

Core AI00%

Other AI10.16%

Non-AI workforce62899.84%

Web traffic by country

22K monthly visits
across markets

🇺🇸 United States53.2%

🇮🇳 India15.9%

🇬🇧 United Kingdom10%

🇨🇦 Canada8.6%

🇯🇵 Japan5%

Top 5 markets shown

Patent intelligence

$164M patent portfolio · 101 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value

$164M

3.5% of market cap · 1.6× the top peer Horizon Therapeutics ($100M)

101 active patent families

Where Amicus Therapeutics innovates PharmacologyMolecular biologyDiseasePharmacological chaperonePharmaceutical drug

Below peer median on Legal, Strategic, Technology

Quality vs same-sector peers

Amicus Therapeutics on the five Patsnap quality dimensions

Amicus Therapeutics in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where Amicus Therapeutics concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across Amicus Therapeutics and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See Amicus Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo